Literature DB >> 2605230

Three novel oligosaccharides with the sialyl-Lea structure in human milk: isolation by immunoaffinity chromatography.

H Kitagawa1, H Nakada, A Kurosaka, N Hiraiwa, Y Numata, S Fukui, I Funakoshi, T Kawasaki, I Yamashina, I Shimada.   

Abstract

We have determined the structures of three novel oligosaccharides isolated from human milk using the monoclonal antibody MSW 113. These oligosaccharides were purified by affinity chromatography on a column of the immobilized monoclonal antibody and by high-performance liquid chromatography. From the results of 500-MHz 1H NMR spectroscopy and fast atom bombardment-mass spectrometry, their structures were deduced to be (formula; see text) These oligosaccharides bound to MSW 113 to nearly the same extent as sialyl-Lea hexasaccharide but bound to another sialyl-Lea structure-directed monoclonal antibody, NS 19-9, only weakly.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2605230     DOI: 10.1021/bi00448a031

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  4 in total

1.  In vitro alpha1-3 or alpha1-4 fucosylation of type I and II oligosaccharides with secreted forms of recombinant human fucosyltransferases III and VI.

Authors:  M Nimtz; E Grabenhorst; U Gambert; J Costa; V Wray; M Morr; J Thiem; H S Conradt
Journal:  Glycoconj J       Date:  1998-09       Impact factor: 2.916

Review 2.  Structures and application of oligosaccharides in human milk.

Authors:  Akira Kobata
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2010       Impact factor: 3.493

Review 3.  The trail of my studies on glycoproteins from enterokinase to tumor markers.

Authors:  Ikuo Yamashina
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2010       Impact factor: 3.493

Review 4.  Human Milk Oligosaccharides (HMOS): Structure, Function, and Enzyme-Catalyzed Synthesis.

Authors:  Xi Chen
Journal:  Adv Carbohydr Chem Biochem       Date:  2015-11-11       Impact factor: 3.714

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.